Durvalumab and Tremelimumab for Pediatric Malignancies
AstraZeneca
AstraZeneca
AstraZeneca
Eli Lilly and Company
Lumos Pharma
NeoImmuneTech
Bristol-Myers Squibb
University of Maryland, Baltimore
Transgene
Teva Branded Pharmaceutical Products R&D, Inc.
Cytovation AS
Eli Lilly and Company
Cytovation AS
Shasqi, Inc.
Constellation Pharmaceuticals
Bristol-Myers Squibb
University of California, San Diego
BeiGene
Anaveon AG
Palleon Pharmaceuticals, Inc.
Taiho Oncology, Inc.
CytomX Therapeutics
Hoffmann-La Roche
Numab Therapeutics AG
Thomas Jefferson University
Thomas Jefferson University
Faron Pharmaceuticals Ltd
Celgene
Intensity Therapeutics, Inc.
BeiGene
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Takeda
Atara Biotherapeutics
Daiichi Sankyo
Herlev Hospital
GlaxoSmithKline
University of California, San Diego
Altor BioScience
Hutchmed
Altor BioScience
Basilea Pharmaceutica
Altor BioScience
Altor BioScience
Servier
Theseus Pharmaceuticals
Sumitomo Pharma America, Inc.
Jounce Therapeutics, Inc.
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Advaxis, Inc.
University of Virginia